Följ
Anna Belkina
Anna Belkina
Boston University School of Medicine
Verifierad e-postadress på bu.edu
Titel
Citeras av
Citeras av
År
BET domain co-regulators in obesity, inflammation and cancer
AC Belkina, GV Denis
Nature reviews Cancer 12 (7), 465-477, 2012
7552012
B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile
J DeFuria, AC Belkina, M Jagannathan-Bogdan, J Snyder-Cappione, ...
Proceedings of the National Academy of Sciences 110 (13), 5133-5138, 2013
5562013
B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile
J DeFuria, AC Belkina, M Jagannathan-Bogdan, J Snyder-Cappione, ...
Proceedings of the National Academy of Sciences 110 (13), 5133-5138, 2013
5562013
BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses
AC Belkina, BS Nikolajczyk, GV Denis
The Journal of Immunology 190 (7), 3670-3678, 2013
4342013
Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets
AC Belkina, CO Ciccolella, R Anno, R Halpert, J Spidlen, ...
Nature communications 10 (1), 5415, 2019
3902019
Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation
LP Bharath, M Agrawal, G McCambridge, DA Nicholas, H Hasturk, J Liu, ...
Cell metabolism 32 (1), 44-55. e6, 2020
3542020
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
C Banerjee, N Archin, D Michaels, AC Belkina, GV Denis, J Bradner, ...
Journal of leukocyte biology 92 (6), 1147-1154, 2012
3432012
Brd2 disruption in mice causes severe obesity without Type 2 diabetes
F Wang, H Liu, WP Blanton, A Belkina, NK Lebrasseur, GV Denis
Biochemical Journal 425 (1), 71-85, 2010
2692010
Clinical trials for BET inhibitors run ahead of the science
G Andrieu, AC Belkina, GV Denis
Drug Discovery Today: Technologies 19, 45-50, 2016
2572016
Th17 cytokines differentiate obesity from obesity‐associated type 2 diabetes and promote TNF α production
B Ip, NA Cilfone, AC Belkina, J DeFuria, M Jagannathan‐Bogdan, M Zhu, ...
Obesity 24 (1), 102-112, 2016
1202016
Fatty acid metabolites combine with reduced β oxidation to activate Th17 inflammation in human type 2 diabetes
DA Nicholas, EA Proctor, M Agrawal, AC Belkina, SC Van Nostrand, ...
Cell metabolism 30 (3), 447-461. e5, 2019
1172019
Obesity genes and insulin resistance
AC Belkina, GV Denis
Current Opinion in Endocrinology, Diabetes and Obesity 17 (5), 472-477, 2010
1002010
BET bromodomain proteins Brd2, Brd3 and Brd4 selectively regulate metabolic pathways in the pancreatic β-cell
JT Deeney, AC Belkina, OS Shirihai, BE Corkey, GV Denis
PloS one 11 (3), e0151329, 2016
812016
Lung-resident memory B cells protect against bacterial pneumonia
KA Barker, NS Etesami, AT Shenoy, EI Arafa, CL de Ana, NMS Smith, ...
The Journal of clinical investigation 131 (11), 2021
702021
HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction
H Akiyama, CM Miller, CR Ettinger, AC Belkina, JE Snyder-Cappione, ...
Nature communications 9 (1), 3450, 2018
682018
Antigen presentation by lung epithelial cells directs CD4+ TRM cell function and regulates barrier immunity
AT Shenoy, C Lyon De Ana, EI Arafa, I Salwig, KA Barker, FT Korkmaz, ...
Nature Communications 12 (1), 5834, 2021
662021
The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis
AC Belkina, WP Blanton, BS Nikolajczyk, GV Denis
Journal of Leukocyte Biology 95 (3), 451-460, 2014
622014
Pneumonia recovery reprograms the alveolar macrophage pool
A Guillon, EI Arafa, KA Barker, AC Belkina, I Martin, AT Shenoy, ...
JCI insight 5 (4), 2020
512020
Role of Fas and Treg cells in fracture healing as characterized in the Fas‐deficient (lpr) mouse model of lupus
MO Al‐Sebaei, DM Daukss, AC Belkina, S Kakar, NA Wigner, D Cusher, ...
Journal of Bone and Mineral Research 29 (6), 1478-1491, 2014
462014
BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response
GP Andrieu, JS Shafran, CL Smith, AC Belkina, AN Casey, N Jafari, ...
Cancer letters 465, 45-58, 2019
452019
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20